Chair: Yu Jo Chua
An update on sigNETure – the NETs registry (#41)
4:00 PM
CONTROL NETS: Capecitabine ON Temozolomide Radionuclide therapy Octreotate Lutetium-177 NeuroEndocrine Tumours Study (#42)
4:10 PM
Visualising Therapy: Evolving role of nuclear medicine in Management of Metastatic Neuroendocrine Tumours (#43)
4:30 PM
Cardiac Valve Surgery in patients with Carcinoid Heart Disease (#44)
4:50 PM
The Patient and Carer Perspective of NETs – What have we learnt and direction for the future (#45)
5:10 PM